BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 26987790)

  • 1. Minimal energy requirement for external cardioversion and catheter ablation for long-standing persistent atrial fibrillation.
    Kim IS; Kim TH; Yang PS; Uhm JS; Joung B; Lee MH; Pak HN
    J Cardiol; 2017 Jan; 69(1):162-168. PubMed ID: 26987790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Pulmonary Vein Anatomy on the Outcomes of Catheter Ablation for Atrial Fibrillation.
    Istratoaie S; Roșu R; Cismaru G; Vesa ȘC; Puiu M; Zdrenghea D; Pop D; Buzoianu AD
    Medicina (Kaunas); 2019 Nov; 55(11):. PubMed ID: 31690031
    [No Abstract]   [Full Text] [Related]  

  • 3. Usefulness of Failed Electrical Cardioversion for Early Recurrence After Catheter Ablation for Atrial Fibrillation as a Predictor of Future Recurrence.
    Nakamaru R; Tanaka N; Okada M; Tanaka K; Ninomiya Y; Hirao Y; Oka T; Inoue H; Koyama Y; Okamura A; Iwakura K; Rakugi H; Sakata Y; Fujii K; Inoue K
    Am J Cardiol; 2019 Mar; 123(5):794-800. PubMed ID: 30558757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of early versus delayed elective electrical cardioversion for recurrent episodes of persistent atrial fibrillation: A multi-center study.
    Voskoboinik A; Kalman E; Plunkett G; Knott J; Moskovitch J; Sanders P; Kistler PM; Kalman JM
    Int J Cardiol; 2019 Jun; 284():33-37. PubMed ID: 30917880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of combination of transcatheter atrial septal defects closure and radiofrequency catheter ablation for the prevention of atrial fibrillation recurrence through bi-atrial reverse remodeling.
    Kamioka M; Yoshihisa A; Hijioka N; Nodera M; Yamada S; Kaneshiro T; Oikawa M; Kobayashi A; Kunii H; Takeishi Y
    J Interv Card Electrophysiol; 2020 Nov; 59(2):365-372. PubMed ID: 31776769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of catheter ablation of atrial fibrillation on the left atrial volume and function: study using three-dimensional echocardiography.
    Hwang J; Park HS; Han S; Jun SW; Kang NY; Jeon JH; Choi SW; Lee CH; Kim IC; Cho YK; Yoon HJ; Kim H; Nam CW; Hur SH
    J Interv Card Electrophysiol; 2020 Jan; 57(1):87-95. PubMed ID: 31889225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced interatrial block is an electrocardiographic marker for recurrence of atrial fibrillation after electrical cardioversion.
    Fujimoto Y; Yodogawa K; Maru YJ; Oka E; Hayashi H; Yamamoto T; Iwasaki YK; Hayashi M; Shimizu W
    Int J Cardiol; 2018 Dec; 272():113-117. PubMed ID: 30072150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epicardial fat thickness: A new predictor of successful electrical cardioversion and atrial fibrillation recurrence.
    Dereli S; Bayramoğlu A; Yontar OC; Cerşit S; Gürsoy MO
    Echocardiography; 2018 Dec; 35(12):1926-1931. PubMed ID: 30387182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum relaxin level predicts recurrence of atrial fibrillation after radiofrequency catheter ablation.
    Qu X; Chen L; Sun L; Chen C; Gao Z; Huang W; Zhou H
    Heart Vessels; 2019 Sep; 34(9):1543-1551. PubMed ID: 30937522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Amiodarone Pre-Treatment as a Facilitator of the Acute Success of Electrical Cardioversion in Persistent Atrial Fibrillation.
    Alegret JM; Viñolas X; Tajes H; Valdovinos P; Palomares R; Arias MA; Bazán V
    Cardiovasc Drugs Ther; 2020 Feb; 34(1):89-94. PubMed ID: 32096001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staged hybrid procedure versus radiofrequency catheter ablation in the treatment of atrial fibrillation.
    Hwang JK; Jeong DS; Gwag HB; Park KM; Ahn J; Carriere K; Park SJ; Kim JS; On YK
    PLoS One; 2018; 13(10):e0205431. PubMed ID: 30300413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left atrial longitudinal strain by speckle tracking as independent predictor of recurrence after electrical cardioversion in persistent and long standing persistent non-valvular atrial fibrillation.
    Moreno-Ruiz LA; Madrid-Miller A; Martínez-Flores JE; González-Hermosillo JA; Arenas-Fonseca J; Zamorano-Velázquez N; Mendoza-Pérez B
    Int J Cardiovasc Imaging; 2019 Sep; 35(9):1587-1596. PubMed ID: 30993507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early choice for catheter ablation reduced readmission in management of atrial fibrillation: Impact of diagnosis-to-ablation time.
    Kawaji T; Shizuta S; Yamagami S; Aizawa T; Komasa A; Yoshizawa T; Kato M; Yokomatsu T; Miki S; Ono K; Kimura T
    Int J Cardiol; 2019 Sep; 291():69-76. PubMed ID: 30948218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardioversion efficacy of nifekalan in patients with sustained atrial fibrillation after radiofrequency ablation].
    Li F; Xia Z; Yu JH; Chen Q; Hu JZ; Zhu B; Xia ZR; Huang QH; Li JX; Hong K; Wu YQ; Cheng XS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Dec; 47(12):963-968. PubMed ID: 31877591
    [No Abstract]   [Full Text] [Related]  

  • 15. Elongation of the high right atrium to coronary sinus conduction time predicts the recurrence of atrial fibrillation after radiofrequency catheter ablation.
    Kanemaru Y; Arima Y; Kaikita K; Kiyama T; Kaneko S; Ito M; Yamabe H; Motozato K; Yamanaga K; Fujisue K; Sueta D; Takashio S; Araki S; Usuku H; Nakamura T; Fukunaga T; Suzuki S; Izumiya Y; Sakamoto K; Soejima H; Yamamoto E; Kawano H; Kanazawa H; Tsujita K
    Int J Cardiol; 2020 Feb; 300():147-153. PubMed ID: 31785957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial conduit function quantitation precardioversion predicts early arrhythmia recurrence in persistent atrial fibrillation patients.
    Giubertoni A; Boggio E; Ubertini E; Zanaboni J; Calcaterra E; Degiovanni A; Bellacosa I; Marino PN;
    J Cardiovasc Med (Hagerstown); 2019 Apr; 20(4):169-179. PubMed ID: 30829875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation-Insights from the German Ablation Registry.
    Schleberger R; Metzner A; Kuck KH; Andresen D; Willems S; Hoffmann E; Deneke T; Eckardt L; Brachmann J; Hochadel M; Senges J; Rillig A
    Pharmacol Res Perspect; 2021 Dec; 9(6):e00880. PubMed ID: 34664789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-Year Change in the Renal Function After Catheter Ablation of Atrial Fibrillation.
    Park JW; Yang PS; Bae HJ; Yang SY; Yu HT; Kim TH; Uhm JS; Joung B; Lee MH; Pak HN
    J Am Heart Assoc; 2019 Sep; 8(17):e013204. PubMed ID: 31474174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left atrial structure and function predictors of recurrent fibrillation after catheter ablation: a systematic review and meta-analysis.
    Bajraktari G; Bytyçi I; Henein MY
    Clin Physiol Funct Imaging; 2020 Jan; 40(1):1-13. PubMed ID: 31556215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Long-Term Cost-Effectiveness Analysis Comparing Radiofrequency Catheter Ablation with Antiarrhythmic Drugs in Treatment of Chinese Patients with Atrial Fibrillation.
    Du X; He X; Jia Y; Wu J; Long D; Yu R; Sang C; Yin H; Xuan J; Dong J; Ma C
    Am J Cardiovasc Drugs; 2019 Dec; 19(6):569-577. PubMed ID: 31090018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.